Novartis’ radiotherapy Pluvicto nabs FDA approval for prostate cancer, with $2B-plus peak sales expectationsMarch 24, 2022Novartis wins FDA OK for radiopharmaceutical drug, cashing in on Endocyte dealMarch 24, 2022 0 Published by at March 24, 2022 Categories Tags Sobi to trim staff as Pfizer manufacturing contract ends early jkeenan Thu, 03/24/2022 – 08:40
